Home     About SABCS     Press Releases     Media     Event Photos     Past Symposia     Satellite Symposia     Patient Advocates     FAQs     Contact Us



SABCS 2014 Resources     Registration     Hotel     Presenter Instructions     Support & Exhibits     2014 Overview     Program     Faculty     Travel & Transportation    

Registration Categories & Fees
Patient Advocate Mentor Sessions
Financial Assistance
Advocate Program

Patient Advocates

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

 
Spacer

Registration Categories & Fees
Category
Price
 
   Until 10/31/14   $125.00
   
   Beginning 11/1/14
  $150.00

(When registering you must provide name of organization you are representing)

Click here to register and for further registration information.

Pre-registration discount ends October 31, 2014.

Pre-registration closes November 14, 2014.
On site registration opens December 9, 2014.

Top
 
Spacer

Patient Advocate Mentor Sessions
The Alamo Breast Cancer Foundation runs a grassroots advocacy program to eradicate the presence of breast cancer in our society.

Every year, Alamo Breast Cancer Foundation sponsors special mentoring sessions for patient advocates at SABCS. These usually take place 5 PM – 8 PM on Wednesday, Thursday & Friday during the symposium.

Leading experts in the field of breast cancer provide commentary on symposium presentations and responding to advocates’ questions about the relevance of this scientific data.

Top
 
Spacer

Financial Assistance

Every year the Alamo Breast Cancer Foundation provides scholarships for eligible breast cancer advocates to attend the annual San Antonio Breast Cancer Symposium, and take part in Mentor Sessions.

Website
Information regarding the 2014 ABCF Advocate Program can be found at www.alamobreastcancer.org.  This page also includes a link to an on line application.

E-Mail
sandistanford@alamobreastcancer.org for information and an application.

All applications for financial assistance must be submitted by 10PM CST by September 1, 2014.

Top
 
Spacer

Advocate Program

The 17th Annual Advocate Program is sponsored by Alamo Breast Cancer Foundation (ABCF), a non-profit 501[c]3 organization. This San Antonio-based grassroots advocacy, educational, and support organization was established for women and men with breast cancer and for those concerned about breast cancer issues. ABCF is active locally and nationally (as members of the National Breast Cancer Coalition) in their goal to eradicate breast cancer in our lifetime.


The 1st Annual Advocate Program was held in 1998, in conjunction with the 21st Annual San Antonio Breast Cancer Symposium, as an educational program specially designed to address the needs of patient advocates and those who support them. The program for 2014 will include Orientation, Dinner, Mentors Program, two Educational programs and Breast Cancer Update for the grant recipients. 40-50 travel grants are expected to be available for 2012, pending receipt of sufficient grant funds.


The administration of this program is handled entirely by Alamo Breast Cancer Foundation. Their 2014 proposal will be mailed to a select list in June, and we hope you will support their program in addition to the 37th Annual San Antonio Breast Cancer Symposium.


Contact Information:
Sandi Stanford
Alamo Breast Cancer Foundation
PO Box 780067
San Antonio, TX 78278
Email: sandistanford@alamobreastcancer.org
Website Address: www.alamobreastcancer.org

Year
Funding Sources
# Travel Grants Applications
# Travel Grants Awarded
Total # Advocate Registration to SABCS
1998
Glaxo Wellcome Eli Lilly Zeneca
14
14
82
1999
Bristol-Myers Genentech Wyeth-Ayerst
42
30
104
2000
Aventis Genentech AstraZeneca
Glaxo Wellcome Pharmacia Oncology
62
50
123
2001
AstraZeneca Aventis Bristol-Meyers Squibb Chroma Vision Eli Lilly Genentech GlaxoSmithKline Pharmacia
52
36
118
2002
AstraZeneca Aventis Bristol-Myers Squibb
ChromaVision DakoCytomation Eli Lilly
Genentech GlaxoSmithKline Pharmacia
40
28
119
2003

AstraZeneca Pharmaceuticals

Bristol Myers Squibb Chromavision DakoCytomation Eli Lilly & Co Genentech Genomic Health GlaxoSmithKline Pfizer

52
37
168
2004
AstraZeneca Pharmaceuticals DakoCytomatic, Inc. Genentech, Inc. Genomic Health, Inc. GlaxoSmithKline Introgen Therapeutics, Inc. Sanofi-Aventis
52
37
168
2005

AstraZeneca Pharmaceuticals Cytyc

Eli Lilly & Company Genentech Genomic Health GlaxoSmithKline

Introgen Therapeutics Sanofi-Aventis

49
32
201
2006

Avon Foundation NBCC Fund--Best Practices Award AstraZeneca Genentech

Genomic Health Eli Lilly Sanofi-Aventis

109
43
199
2007

Abraxis Oncology AstraZeneca

Avon Foundation Genentech GlaxoSmithKline Novartis Roche Introgen Therapeutics

Sanofi-Aventis Dr. Sharon Wilks

109
42
233
2008

Abraxane-AZ AstraZeneca Avon Foundation Cytori Genentech BioOncology

Genomic Health, Inc. GlaxoSmithKline

Her2 Support Novartis Roche Sanofi-Aventis Dr. Sharon Wilks

34
32
225
2009

Abraxis BioOncology AstraZeneca

Avon Foundation for Women
Cytori Therapeutics, Inc Eli Lilly & Co Genentech Genomic Health, Inc
GlaxoSmithKline Her2 Support Group Organization National Breast
Cancer Coalition Novartis Pharmaceuticals Corp Sanofi-Aventis

Dr. Sharon Wilks, MD, FACP

Dr. Peter Ravdin, MD, PhD

82
36
235
2010

AACR Abraxis BioOncology Amgen AstraZeneca Avon Foundation for Women Eisai, Inc. Eli Lilly & Co. Genentech
GlaxoSmithKline Novartis Pharmaceuticals Corporation Dr. Peter Ravdin, MD, PhD Sanofi-Aventis Dr Sharon Wilks, MD, FACP

107
32
297
2011

AACR Amgen Avon Foundation for Women

Boehringer Ingelheim Genentech

Genomic Health, Inc. GlaxoSmithKline

Julie Ann Carpenter Memorial Fund

Novartis Pharmaceuticals Corp

Peter Ravdin, MD, PhD

Sharon Wilks, MD, FACP Syndax

119
41
298
2012

AACR Amgen Avon Foundation for Women

Celgene Corporation Genentech

Genomic Health, Inc GlaxoSmithKline

Julie Ann Carpenter Memorial Fund

Nektar Novartis Pharmaceuticals Corp

Peter Ravdin, MD, PhD

68
31
144
2013

AACR Amgen AstraZeneca

Avon Foundation for Women

Celgene Corporation Genentech

Genomic Health

Julie Ann Carpenter Memorial Fund

Novartis Pharmaceuticals

Peter Ravdin, MD, PhD SABCS

Sharon Wilks, MD, FACP

61
23
171

 

Top
 
 
Home | About SABCS | Press Releases | Media | Event Photos | Past Symposia | Satellite Symposia | Patient Advocates | FAQs | Contact Us
SABCS 2014 Resources | Registration | Hotel | Presenter Instructions | Support & Exhibits | 2014 Overview | Program | Faculty | Travel & Transportation

Rich Markow, Director, Symposia
Cancer Therapy & Research Center at UT Health Science Center San Antonio

7979 Wurzbach Road, MC 8224 San Antonio, TX 78229 USA
Phone: 210-450-1550    Fax: 210-450-1560    Email: sabcs@uthscsa.edu
     line
Copyright 2014 SABCS. All rights reserved. - Privacy Policy